Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Mar;61(3):191–192. doi: 10.1136/ard.61.3.191

Prophylactic use of antibiotics and immunisations in patients with SLE

W Gilliland 1, G Tsokos 1
PMCID: PMC1754039  PMID: 11830419

Full Text

The Full Text of this article is available as a PDF (86.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andonopoulos A. P., Safridi C., Karokis D., Bounas A. Is a purified protein derivative skin test and subsequent antituberculous chemoprophylaxis really necessary in systemic rheumatic disease patients receiving corticosteroids? Clin Rheumatol. 1998;17(3):181–185. doi: 10.1007/BF01451043. [DOI] [PubMed] [Google Scholar]
  2. Balakrishnan C., Mangat G., Mittal G., Joshi V. R. Tuberculosis in patients with systemic lupus erythematosus. J Assoc Physicians India. 1998 Aug;46(8):682–683. [PubMed] [Google Scholar]
  3. Battafarano D. F., Battafarano N. J., Larsen L., Dyer P. D., Older S. A., Muehlbauer S., Hoyt A., Lima J., Goodman D., Lieberman M. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum. 1998 Oct;41(10):1828–1834. doi: 10.1002/1529-0131(199810)41:10<1828::AID-ART15>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  4. Croft S. M., Schiffman G., Snyder E., Herrmann K., James K., Jarrett M. P. Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus. J Rheumatol. 1984 Apr;11(2):141–146. [PubMed] [Google Scholar]
  5. Dajani A. S., Taubert K. A., Wilson W., Bolger A. F., Bayer A., Ferrieri P., Gewitz M. H., Shulman S. T., Nouri S., Newburger J. W. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. 1997 Jun 11;277(22):1794–1801. [PubMed] [Google Scholar]
  6. Gaitonde S., Pathan E., Sule A., Mittal G., Joshi V. R. Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment. Ann Rheum Dis. 2002 Mar;61(3):251–253. doi: 10.1136/ard.61.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ginzler E., Diamond H., Kaplan D., Weiner M., Schlesinger M., Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 1978 Jan-Feb;21(1):37–44. doi: 10.1002/art.1780210107. [DOI] [PubMed] [Google Scholar]
  8. HARVEY A. M., SHULMAN L. E., TUMULTY P. A., CONLEY C. L., SCHOENRICH E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954 Dec;33(4):291–437. [PubMed] [Google Scholar]
  9. Herron A., Dettleff G., Hixon B., Brandwin L., Ortbals D., Hornick R., Hahn B. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA. 1979 Jul 6;242(1):53–56. [PubMed] [Google Scholar]
  10. Iliopoulos A. G., Tsokos G. C. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1996 Apr;25(5):318–336. doi: 10.1016/s0049-0172(96)80018-7. [DOI] [PubMed] [Google Scholar]
  11. Janwityanuchit S., Totemchokchyakarn K., Krachangwongchai K., Vatanasuk M. Infection in systemic lupus erythematosus. J Med Assoc Thai. 1993 Oct;76(10):542–548. [PubMed] [Google Scholar]
  12. Kim H. A., Yoo C. D., Baek H. J., Lee E. B., Ahn C., Han J. S., Kim S., Lee J. S., Choe K. W., Song Y. W. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol. 1998 Jan-Feb;16(1):9–13. [PubMed] [Google Scholar]
  13. Liam C. K., Wang F. Pneumocystis carinii pneumonia in patients with systemic lupus erythematosus. Lupus. 1992 Dec;1(6):379–385. doi: 10.1177/096120339200100607. [DOI] [PubMed] [Google Scholar]
  14. Lipnick R. N., Karsh J., Stahl N. I., Blackwelder W. C., Schiffman G., Klippel J. H. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol. 1985 Dec;12(6):1118–1121. [PubMed] [Google Scholar]
  15. Maillefert J. F., Sibilia J., Toussirot E., Vignon E., Eschard J. P., Lorcerie B., Juvin R., Parchin-Geneste N., Piroth C., Wendling D. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) 1999 Oct;38(10):978–983. doi: 10.1093/rheumatology/38.10.978. [DOI] [PubMed] [Google Scholar]
  16. Massardo L., Martínez M. E., Jacobelli S., Villarroel L., Rosenberg H., Rivero S. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum. 1994 Aug;24(1):1–11. doi: 10.1016/0049-0172(94)90094-9. [DOI] [PubMed] [Google Scholar]
  17. Nossent J. C. Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients. Semin Arthritis Rheum. 1993 Aug;23(1):16–21. doi: 10.1016/s0049-0172(05)80023-x. [DOI] [PubMed] [Google Scholar]
  18. Older S. A., Battafarano D. F., Enzenauer R. J., Krieg A. M. Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum. 1999 Dec;29(3):131–139. doi: 10.1016/s0049-0172(99)80024-9. [DOI] [PubMed] [Google Scholar]
  19. Phan J. C., Bush T. M., Donald F., Ward M. Clinical and laboratory features of patients of Vietnamese descent with systemic lupus erythematosus. Lupus. 1999;8(7):521–524. doi: 10.1191/096120399678840774. [DOI] [PubMed] [Google Scholar]
  20. Pistiner M., Wallace D. J., Nessim S., Metzger A. L., Klinenberg J. R. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991 Aug;21(1):55–64. doi: 10.1016/0049-0172(91)90057-7. [DOI] [PubMed] [Google Scholar]
  21. Porges A. J., Beattie S. L., Ritchlin C., Kimberly R. P., Christian C. L. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol. 1992 Aug;19(8):1191–1194. [PubMed] [Google Scholar]
  22. Rosner S., Ginzler E. M., Diamond H. S., Weiner M., Schlesinger M., Fries J. F., Wasner C., Medsger T. A., Jr, Ziegler G., Klippel J. H. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 1982 Jun;25(6):612–617. doi: 10.1002/art.1780250602. [DOI] [PubMed] [Google Scholar]
  23. Sneller M. C., Hoffman G. S., Talar-Williams C., Kerr G. S., Hallahan C. W., Fauci A. S. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum. 1995 May;38(5):608–613. doi: 10.1002/art.1780380505. [DOI] [PubMed] [Google Scholar]
  24. Stuart R. L., Wilson J., Grayson M. L. Isoniazid toxicity in health care workers. Clin Infect Dis. 1999 Apr;28(4):895–897. doi: 10.1086/515221. [DOI] [PubMed] [Google Scholar]
  25. Zysset M. K., Montgomery M. T., Redding S. W., Dell'Italia L. J. Systemic lupus erythematosus: a consideration for antimicrobial prophylaxis. Oral Surg Oral Med Oral Pathol. 1987 Jul;64(1):30–34. doi: 10.1016/0030-4220(87)90112-5. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES